MTEM Molecular Templates, Inc. revenue, earnings and financials
For the quarter ended June 30, 2024, Molecular Templates, Inc. reported revenue of n/a, net income of −$8.10M and diluted EPS of $1.23; for the fiscal year ended December 2023 revenue was n/a.
MTEM annual revenue and earnings
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$10.5M, net income −$8.12M (margin n/a), EPS −$1.80
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$88.9M, net income −$92.7M (margin n/a), EPS −$24.69
- Fiscal year ended Dec 2021: revenue n/a, gross profit n/a, operating income −$80.1M, net income −$83.0M (margin n/a), EPS −$1.50
MTEM quarterly revenue and earnings
- Quarter ended Jun 30, 2024: revenue n/a, net income −$8.10M, EPS $1.23
- Quarter ended Mar 31, 2024: revenue n/a, net income $572K, EPS −$0.08
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income −$3.95M, EPS −$0.98
- Quarter ended Sep 30, 2023: revenue n/a, net income −$4.15M, EPS −$0.82
- Quarter ended Jun 30, 2023: revenue n/a, net income −$10.9M, EPS $2.89
- Quarter ended Mar 31, 2023: revenue n/a, net income $10.8M, EPS −$2.89
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$22.0M, EPS −$18.08
- Quarter ended Sep 30, 2022: revenue n/a, net income −$24.6M, EPS −$6.56
- Quarter ended Jun 30, 2022: revenue n/a, net income −$24.4M, EPS −$0.43
- Quarter ended Mar 31, 2022: revenue n/a, net income −$21.6M, EPS $0.38
- Quarter ended Dec 31, 2021 (from the annual report): revenue n/a, net income −$10.2M, EPS −$0.17
- Quarter ended Sep 30, 2021: revenue n/a, net income −$30.4M, EPS −$0.54
- Quarter ended Jun 30, 2021: revenue n/a, net income −$15.6M, EPS −$0.28
- Quarter ended Mar 31, 2021: revenue n/a, net income −$26.8M, EPS −$0.51
MTEM cash flow, buybacks and dividends
- Fiscal year ended Dec 2023: operating cash flow −$41.8M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$89.0M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow −$30.4M, share buybacks n/a
MTEM balance sheet
- Jun 30, 2024: cash $9.66M, total assets $26.7M, total liabilities $19.6M, shareholders' equity $7.11M
- Mar 31, 2024: cash $6.78M, total assets $27.1M, total liabilities $21.2M, shareholders' equity $5.87M
- Dec 31, 2023: cash $11.5M, total assets $35.4M, total liabilities $31.2M, shareholders' equity $4.21M
- Sep 30, 2023: cash $15.8M, total assets $44.1M, total liabilities $37.3M, shareholders' equity $6.80M
- Jun 30, 2023: cash $4.95M, total assets $35.5M, total liabilities $44.2M, shareholders' equity −$8.68M
- Mar 31, 2023: cash $38.8M, total assets $78.5M, total liabilities $80.4M, shareholders' equity −$1.91M, long-term debt $36.4M
- Dec 31, 2022: cash $32.2M, total assets $97.5M, total liabilities $113M, shareholders' equity −$15.1M, long-term debt $36.2M
- Sep 30, 2022: cash $22.3M, total assets $119M, total liabilities $114M, shareholders' equity $4.15M, long-term debt $35.9M
Is MTEM profitable?
No. Molecular Templates, Inc. lost $15.6M over the last four quarters.
What is MTEM's EPS?
Diluted earnings per share over the last four quarters were −$0.65; $1.23 in the latest quarter.